AzTrials
AzTrials

AmputationQUAPSYNCT05989113

Psychometric Qualities IPAQ-SF

An observational study of Amputation and Lower Extremity Amputation, run by FondationbHopale at 3 sites in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This is an observational, prospective multicentric study designed to develop medical knowledge. The aim of the study is to validate the IPAQ-SF questionnaire in a population of lower limb amputee patients. Read more about this study

Who is it for?
Ages 15 to 69 years
What is being tested?
Administration of the IPAQ-SF questionnaire
How many people
100 participants
Where
3 sitesFrance
Study dates
3 May 2023to Sep 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 69 years
  • All sexes
  • Child, Adult, Older adult

Study population: Lower limb amputee patients with devices

Who may be able to join

  • Patients who have undergone a major lower limb amputation: transtibial, transfemoral, hip or knee disarticulation or trans-iliolumbar
  • Fitting more than 1 year old
  • Age 15-69 years (IPAQ-SF not validated outside these ages)
  • All causes of amputation (vascular, traumatic, tumor, infectious...)
  • Patient having given their informed consent
  • Patient affiliated to a social security system

Who cannot join

  • Subjects with bilateral amputations
  • Inability to fully and adequately understand the questionnaire (i.e., cognitive impairment, patient does not speak French)
  • Contraindication to the 6-minute walk test (chest pain, palpitations, mental confusion or lack of coordination and balance, dizziness or malaise, intolerable dyspnea, leg cramps or extreme leg muscle fatigue, any other clinically justified reason).
  • Patients under legal protection (under guardianship, under curatorship, safeguard of justice)
  • Pregnant or breast-feeding woman

Trial locations and contacts

3 sites in 1 country.

France3 sites, 3 recruiting
  • Institut Calvé

    Berck

    Marine Deseur, 03 62 88 27 80

    Recruiting
  • CHRU Lille - Hôpital Swynghedauw

    Lille, 59037

    Elias GHEHIOUECHE

    Recruiting
  • CRF les HAUTOIS- CRO

    Oignies, 62590

    Elias GHEHIOUECHE

    Recruiting

Other trials in France

About this study

Official title: Evaluation of the Psychometric Qualities of the International Physical Activity Questionnaire-Short Form (IPAQ-SF) in Patients With Lower Limb Amputations (QUAPSY)

This is an observational, prospective multicentric study designed to develop medical knowledge.

The aim of the study is to validate the IPAQ-SF questionnaire in a population of lower limb amputee patients.

The questionnaire is administered twice to each patient, once during the consultation and again when they return home. Patients also undergo a 6-minute walk test.

Read the detailed description

This is an observational, prospective multicentric study designed to develop medical knowledge.

The IPAQ is an internationally validated questionnaire for measuring physical activity in healthy subjects.

The IPAQ-SF (short format of the IPAQ) assesses overall physical activity and sedentary time during the last seven days. The IPAQ-SF has been used in a population of lower limb amputees on several occasions, but no study of its psychometric qualities in application to this population has been performed to date.

The main objective of the study is therefore to gather a set of arguments allowing the IPAQ-SF to be used in the follow-up consultation of patients with lower limb amputations who are fitted with a device.

This would help health professionals to assess the physical activity of this population and to develop physical activity promotion interventions adapted to their needs.

This study is part of the standard management of patients with lower limb amputations and devices. In addition to the clinical data and the result of the 6-minute test from the classical management, the IPAQ-SF questionnaire will be completed twice by the patients included in this study:

  • Once during the consultation,
  • Once at home.

For the only center equipped (center 01) with inertial sensors, the gait parameters during the 6-minute test will be collected in order to extract fatigue indices.

Upon completion of the IPAQ-SF questionnaire a second time, the patient's participation in the study ends.

Being tested
Administration of the IPAQ-SF questionnaire

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Administration of the IPAQ-SF questionnaireOther

    Administration of the IPAQ-SF questionnaire at the patient's consultation and upon return home

Study groups in NCT05989113
Study groupRoleWhat they receive
Lower limb amputee patients with devicesNot described
Receives: Other: Administration of the IPAQ-SF questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Correlation of the METs/week questionnaire results with the results of the 6-minute walk test

    The results of the IPAQ-SF questionnaire will be expressed in METs/week (Metabolic Equivalent of Task).

    The distance covered by the patient at the end of the 6-minute test will be collected in meters.

    Measured: Data collection during the routine consultation on the day of inclusion

Secondary outcomes (9)
  1. Relationships between the patients ability to perform his or her expected daily functions after rehabilitation (MFCL classification, out of 5 points) and the IPAQ-SF score.

    The MFCL consists of five ordered categories or 'K-levels' that define increasing functional mobility.

    Measured: Data collection during the routine consultation on the day of inclusion

  2. Relationships between the level of amputation and the IPAQ-SF score.

    5 levels of amputation :

    • Hip disarticulation
    • Transfemoral amputation
    • Knee disarticulation
    • Transtibial amputation
    • Trans-iliolumbar amputation

    Measured: Data collection during the routine consultation on the day of inclusion

  3. Relationships between the patient's weight and the IPAQ-SF score.

    Patient's weight in kilogram

    Measured: Data collection during the routine consultation on the day of inclusion

  4. Relationships between type of prosthesis and the IPAQ-SF score.

    Measured: Data collection during the routine consultation on the day of inclusion

  5. Relationships between the age of amputation and the IPAQ-SF score.

    Age of amputation in years

    Measured: Data collection during the routine consultation on the day of inclusion

  6. Relationships between the physical activity level of lower limb amputee patients and the patient's walking speed measured by inertial units during the 6-minute test.

    The 6-min walk test (TM6) measures the greatest distance covered in 6 min of walking around two studs separated by 30 meters.

    Patient's walking speed in meters per second during the 6-minute test.

    Measured: Data collection during the 6-minute routine consultation test on the day of inclusion

  7. Relationship between the physical activity level of patients with lower-limb amputations and the patient's average step length measured by inertial units during the 6-minute test.

    The 6-min walk test (TM6) measures the greatest distance covered in 6 min of walking around two studs separated by 30 meters.

    Patient's average step length in centimeters during the 6-minute test.

    Measured: Data collection during the 6-minute routine consultation test on the day of inclusion

  8. Relationship between the physical activity level of patients with lower-limb amputations and the average width of the patient's step measured by inertial units during the 6-minute test.

    The 6-min walk test (TM6) measures the greatest distance covered in 6 min of walking around two studs separated by 30 meters.

    Patient's average step width in centimeters during the 6-minute test.

    Measured: Data collection during the 6-minute routine consultation test on the day of inclusion

  9. Relationship between the physical activity level of patients with lower-limb amputations and the patient's walking cadence measured by inertial units during the 6-minute test.

    The 6-min walk test (TM6) measures the greatest distance covered in 6 min of walking around two studs separated by 30 meters.

    Number of steps per minute during the 6-minute test.

    Measured: Data collection during the 6-minute routine consultation test on the day of inclusion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Aug 2023
  2. Study start3 May 2023
  3. Primary completionSep 2023 (estimated)
  4. Study completionSep 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05989113
Sponsor's protocol ID
HOP23-RIPH3-09
Acronym
QUAPSY
Status last verified
Apr 2023
First submitted
27 Apr 2023
Last updated
1 Sep 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Amputation and Lower Extremity Amputation, run by FondationbHopale at 3 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 1 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Marine Deseur (0362882780, marine.deseur@fondation-hopale.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Correlation of the METs/week questionnaire results with the results of the 6-minute walk test (time frame: Data collection during the routine consultation on the day of inclusion). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Sep 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in